Farms.com Home   News

Study Supports USDA’s Serotype-Specific Regulatory Framework for Salmonella in Poultry

A recent study has demonstrated that targeting high-virulence Salmonella serotypes in risk management strategies and food safety regulation for poultry products could improve public health outcomes. These findings support the U.S. Department of Agriculture’s (USDA’s) recently published regulatory framework for Salmonella in raw poultry, which, if adopted as-is, will set an enforceable final product standard for five Salmonella serotypes of public health significance (S. Enteritidis, S. Typhimurium, S. I 4,[5],12:i:-, S. Hadar, and S. Muenchen).

The study was conducted in response to the same trend to which the new USDA regulatory framework responds—the fact that, in the U.S., Salmonella prevalence has declined since adopting prevalence-based Salmonella performance standards, but human illnesses have not decreased proportionally.

Historically, outbreak data support that some serotypes are more commonly associated with human illnesses. According to U.S. Centers for Disease Control and Prevention (CDC) FoodNet surveillance data, the three most common serotypes linked to human illness are S. Enteritidis (16 percent of cases), S. Typhimurium (14 percent), and S. Newport (10 percent). Moreover, genomic analyses show some serotypes share common determinants of high virulence (S. Enteritidis, S. Infantis, and S. Typhimurium). On the other hand, some Salmonella serotypes—especially S. Kentucky ST152—are frequently recovered from poultry carcasses, but are less likely to cause human illness than other serotypes.

Scientific literature has also demonstrated that foodborne Salmonella outbreaks are often associated with higher doses of the pathogen, and that mitigating high levels of contamination on poultry products may substantially reduce public health risk.

To investigate the risk of foodborne illnesses resulting from Salmonella contamination of poultry parts with different levels of all serotypes, as well as specific high-virulence and low-virulence serotypes, the researchers employed Quantitative Microbial Risk Assessment (QMRA) and modeled two different datasets for comparison. The first data source is 2012 Baseline parts survey, and the second is 2023 Hazards Analysis and Critical Control Points (HACCP) verification data collected by USDA’s Food Safety and Inspection Service (FSIS).

The researchers defined high levels of Salmonella contamination as products containing more than 1 colony forming unit per gram (CFU/g)—the same threshold for which poultry products would be considered “adulterated” by certain Salmonella serotypes under the new USDA regulatory framework.

Overall, the study concluded that high levels of contamination by high-virulence serotypes is relatively rare in finished chicken parts. At the same time, the risk assessment showed that the majority of public health risk from chicken parts is concentrated in those rare products with high levels of high-virulence serotypes. The study also found that limited public health benefits would be gained from the control of low-virulence serotypes (i.e., S. Kentucky ST152).

The findings support USDA’s serotype-specific regulatory framework for Salmonella in raw poultry parts, in contrast to regulatory policies centered solely on Salmonella prevalence. Not only would the public health benefits be limited should regulatory policy focus on prevalence alone, but it could also have negative consequences, such as facilitating increased prevalence and emergence of possibly high-virulence Salmonella serotypes as reductions of low-virulence serotypes are achieved.

The study was conducted by members of the industry-nonprofit-academia Coalition for Poultry Safety Reform, and was supported by a U.S. Poultry and Egg Association grant.

Source : illinois.edu

Trending Video

CEOs of the Industry – Rob Brenneman, CEO of Brenneman Pork

Video: CEOs of the Industry – Rob Brenneman, CEO of Brenneman Pork

“From Pork Production to Performance Nutrition: A Candid Conversation with One of the Industry’s Most Unconventional Thinkers”

CEOs of the Industry, we sit down with Rob Brenneman, the visionary behind Brenneman Pork, for an unfiltered, in-depth conversation on leadership, survivability, nutrition, and the future of pig farming.

Rob shares how a deep-rooted commitment to **health—both animal and personal—**drives his philosophy and decision-making. From reshaping pork nutrition and advocating for the return of well-marbled, flavorful pork to confronting the ongoing battle with PRRS and other health threats, Rob’s insights reflect decades of hands-on experience and bold innovation.

Key themes include: Nutrition Reimagined: Why the industry went off course—and how Brenneman Pork is leading change by prioritizing gut health, fat quality, and real performance.

Health & Survivability: Rob’s take on biosecurity, disease management, and the systems and protocols that protect both pigs and profitability.

Well-Marbled Pork as Premium Protein: The science, consumer insights, and culinary feedback behind Rob’s mission to reintroduce pork as a premium, flavorful protein.

Sustainability & Farm Culture: How Brenneman Pork balances environmental responsibility with day-to-day positivity and resilience.

Generational Impact: Strategies to attract, inspire, and retain the next wave of pork producers with pride and purpose.

Plus, a fast-paced finale where Rob shares his top pork pick, leadership lessons, and what he’d change overnight in the industry.

Whether you're a producer, nutritionist, policymaker, or future leader, this episode offers a masterclass in where pork production is headed—and how visionaries like Rob are shaping it.